Page last updated: 2024-11-05

tolbutamide and Nephrocalcinosis

tolbutamide has been researched along with Nephrocalcinosis in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Nephrocalcinosis: A condition characterized by calcification of the renal tissue itself. It is usually seen in distal RENAL TUBULAR ACIDOSIS with calcium deposition in the DISTAL KIDNEY TUBULES and the surrounding interstitium. Nephrocalcinosis causes RENAL INSUFFICIENCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frizzell, M1
Larsen, PR1
Field, JB1

Other Studies

1 other study available for tolbutamide and Nephrocalcinosis

ArticleYear
Spontaneous hypoglycemia associated with chronic renal failure.
    Diabetes, 1973, Volume: 22, Issue:7

    Topics: Adult; Aged; Blood Glucose; Dextropropoxyphene; Female; Glucagon; Glucose; Glucose Tolerance Test; H

1973